SHC
Price
$18.13
Change
+$0.36 (+2.03%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
5.07B
12 days until earnings call
Intraday BUY SELL Signals
XGN
Price
$7.48
Change
-$0.40 (-5.08%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
190.9M
12 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SHC vs XGN

SHC vs XGN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
SHC vs. XGN commentary
Oct 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SHC is a Hold and XGN is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for SHC with price predictions
Oct 21, 2026

SHC's Indicator enters downward trend

The Aroon Indicator for SHC entered a downward trend on October 19, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 210 similar instances where the Aroon Indicator formed such a pattern. In 170 of the 210 cases the stock moved lower. This puts the odds of a downward move at 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 25, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SHC as a result. In 54 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.

SHC moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SHC crossed bearishly below the 50-day moving average on September 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SHC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +0.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where SHC advanced for three days, in 187 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

SHC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 35 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating fairly steady price growth. SHC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.618) is normal, around the industry mean (64.450). P/E Ratio (31.175) is within average values for comparable stocks, (2.086). Projected Growth (PEG Ratio) (1.313) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (4.587) is also within normal values, averaging (9.775).

The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

A.I.Advisor
a Summary for XGN with price predictions
Oct 21, 2026

XGN in upward trend: price rose above 50-day moving average on October 21, 2026

XGN moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend. In 29 of 32 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +7.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where XGN advanced for three days, in 182 of 222 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

XGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 156 of 185 cases where XGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 84%.

Bearish Trend Analysis

The 10-day RSI Indicator for XGN moved out of overbought territory on September 28, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In 29 of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at 88%.

The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XGN as a result. In 77 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.

The Moving Average Convergence Divergence Histogram (MACD) for XGN turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In 31 of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. XGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.627) is normal, around the industry mean (64.450). P/E Ratio (-9.610) is within average values for comparable stocks, (2.086). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.592) is also within normal values, averaging (9.775).

The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

FUNDAMENTALS RATINGS
SHC vs XGN: Fundamental Ratings
SHC
XGN
OUTLOOK RATING
1..100
1062
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
40
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
3599
PRICE GROWTH RATING
1..100
4835
P/E GROWTH RATING
1..100
9694
SEASONALITY SCORE
1..100
1650

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XGN's Valuation (40) in the null industry is somewhat better than the same rating for SHC (74). This means that XGN’s stock grew somewhat faster than SHC’s over the last 12 months.

XGN's Profit vs Risk Rating (100) in the null industry is in the same range as SHC (100). This means that XGN’s stock grew similarly to SHC’s over the last 12 months.

SHC's SMR Rating (35) in the null industry is somewhat better than the same rating for XGN (99). This means that SHC’s stock grew somewhat faster than XGN’s over the last 12 months.

XGN's Price Growth Rating (35) in the null industry is in the same range as SHC (48). This means that XGN’s stock grew similarly to SHC’s over the last 12 months.

XGN's P/E Growth Rating (94) in the null industry is in the same range as SHC (96). This means that XGN’s stock grew similarly to SHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SHCXGN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 10 days ago
68%
Bullish Trend 18 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
70%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
COMPARISON
Comparison
Oct 22, 2026
Stock price -- (SHC: $17.77 vs. XGN: $7.88)
Brand notoriety: SHC and XGN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: SHC: 138% vs. XGN: 81%
Market capitalization -- SHC: $5.07B vs. XGN: $190.9M
SHC [@Medical Specialties] is valued at $5.07B. XGN’s [@Medical Specialties] market capitalization is $190.9M. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The average market capitalization across the [@Medical Specialties] industry is $20.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SHC’s FA Score shows that 0 FA rating(s) are green while XGN’s FA Score has 0 green FA rating(s).

  • SHC’s FA Score: 0 green, 5 red.
  • XGN’s FA Score: 0 green, 5 red.
According to our system of comparison, both SHC and XGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SHC’s TA Score shows that 3 TA indicator(s) are bullish while XGN’s TA Score has 5 bullish TA indicator(s).

  • SHC’s TA Score: 3 bullish, 5 bearish.
  • XGN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, XGN is a better buy in the short-term than SHC.

Price Growth

SHC (@Medical Specialties) experienced а +0.23% price change this week, while XGN (@Medical Specialties) price change was -6.41% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.63%. For the same industry, the average monthly price growth was -7.00%, and the average quarterly price growth was +41.94%.

Reported Earning Dates

SHC is expected to report earnings on Nov 03, 2026.

XGN is expected to report earnings on Nov 03, 2026.

Industries' Descriptions

@Medical Specialties (-3.63% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
SHC
Daily Signal:
Gain/Loss:
XGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

SHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, SHC has been loosely correlated with RVTY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if SHC jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHC
1D Price
Change %
SHC100%
-0.89%
RVTY - SHC
53%
Loosely correlated
+0.38%
TMO - SHC
52%
Loosely correlated
+0.97%
CRL - SHC
52%
Loosely correlated
+9.33%
A - SHC
50%
Loosely correlated
+2.74%
MTD - SHC
49%
Loosely correlated
+2.69%
More

XGN and

Correlation & Price change

A.I.dvisor tells us that XGN and SHC have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XGN and SHC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XGN
1D Price
Change %
XGN100%
+6.34%
SHC - XGN
30%
Poorly correlated
-0.89%
NTRA - XGN
29%
Poorly correlated
+1.84%
QDEL - XGN
26%
Poorly correlated
-0.91%
NEO - XGN
26%
Poorly correlated
+2.53%
MXCT - XGN
25%
Poorly correlated
+2.80%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VTES99.640.04
+0.04%
Vanguard Short-Term Tax Exempt Bond ETF (VTES)
CPSD27.26N/A
N/A
Calamos S&P 500 Structured Alt Protection ETF - December (CPSD)
FAB103.69-0.18
-0.17%
First Trust Multi Cap Value AlphaDEX Fund (FAB)
SPCK21.45-0.17
-0.81%
SPAC and New Issue ETF (SPCK)
EPU88.71-0.76
-0.85%
iShares MSCI Peru and Global Exposure ETF (EPU)